Pfizer R&D La Jolla, CA
United States of America (USA)
1 July 2019 - 30 June 2020
Principal institution: Pfizer Inc.
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Pfizer R&D La Jolla, CA published between 1 July 2019 - 30 June 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| Count | Share |
|---|---|
| 9 | 2.03 |
Outputs by subject (Share)
| Subject | Count | Share | |
|---|---|---|---|
| Chemistry | 6 | 1.62 | |
| Life Sciences | 4 | 0.43 | |
| Physical Sciences | 1 | 0.03 | |
Top articles by Altmetric score in current window
CDK4/6 Inhibitors Impair Recovery from Cytotoxic Chemotherapy in Pancreatic Adenocarcinoma.
Cancer Cell
2020-02-07
Antitumor activity of crizotinib in lung cancers harboring a exon 14 alteration
Nature Medicine
2020-01-13
Exploring use of unsupervised clustering to associate signaling profiles of GPCR ligands to clinical response
Nature Communications
2019-09-09
High-Throughput Ligand Screening Enables the Enantioselective Conjugate Borylation of Cyclobutenones to Access Synthetically Versatile Tertiary Cyclobutylboronates
Angewandte Chemie International Edition
2019-10-31
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
